GenomSys

𝗧𝗘𝗖𝗛 𝗪𝗘𝗘𝗞: 𝗧𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 𝗶𝘀 𝗯𝗮𝘀𝗲𝗱 𝗼𝗻 𝗠𝗣𝗘𝗚-𝗚 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱 Our CEO Antonio Aitoro had the chance to join a professional panel at @ITALIAN TECH WEEK 2024 to unleash the power of GenomSys IP, entirely based on the 𝘂𝗻𝗶𝗾𝘂𝗲 𝗠𝗣𝗘𝗚-𝗚 𝗜𝗦𝗢 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱 for genomic data management. GenomSys is leading the change with a strategic approach to full inter-operability by extensive adoption of the standard. Compression, storage, variant analysis and last generation encryption tools are the pillars for future applications and new patents. Stay tuned to our innovation at GenomSys #Genomics #IPManagement #AI #MPEGG #Innovation

𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗶𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝗺𝗲𝗲𝘁𝘀 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 GenomSys is 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 by combining AI and Genomics, making DNA analysis faster, more efficient and accessible. Learn how we’re paving the way for personalized medicine and finding adjacent SW solutions for veterinary genomics. Discover more in the latest episode of AI Talks with Antonio Aitoro (interview of Andrea Fantucchio in Italian) #Genomics #AI #Healthcare #Innovation #Personalizedmedicine @GenomSys.com

We are pleased to announce that GenomSys will be present at the panel "Unlocking Hidden Value: How Intellectual Property and Patents Generate Wealth" at Italian Tech Week 2024. Join us on September 26th at 3PM at the Binario 3 Stage. Speakers Maria Cristina Odasso, Head of Business Analysis at LIFTT, Emilio Alacevich, Business Developer & Specialist in Innovation and Hit-TEch Enterpreneurship at Istituto Italiano di Tecnologia and Antonio Aitoro, CEO of GenomSys. The Panel moderator will be Valerio Capasso, Lawyer & Founder of Toro Legal Hub. We'll focus on the power of #intellectualproperty as a driver to attract investment and to boost our continuos development in the path of innovation and growth Meet us at Italian Tech Week

https://lnkd.in/dbH5Xu-z ... preparing for the next steps of our MPEG-G genomic SW platform we keep straight focus on our Vision to involve new partners and investors in our effort to democratize genomics.

On July 16th, our CEO Antonio Aitoro was pleased to introduce as speaker at B4i - Bocconi for innovation the wonderful GenoGra team, led by Guido Walter Di Donato, PhD. Our partner Company is growing through a new investment round. Find here the short pitch: "Let’s try to focus for only 60 seconds on GENOMICS. DNA sequencing offers us a real understanding of HOW some diseases work and give us the KEY on how they can be beaten. In few words it could be medicine 5.0 without the "tools" of a surgeon ... To deal with genomic data you need some simple assets: data processing power and speed, enormous data storage and very competent people. It happened to me to meet Guido and his mates after one of his interviews on television. They are not only competent data scientists. They are also really compelling people, ethusiasts, able to convey enthusiasm all around. We met, we talked, we drew a common path. Today GENOGRA is not only the main tech supplier of GENOMSYS. but we are co-designing, co-branding and we are going to integrate their GENOME GRAPH solution in our platform as PRIME FEATURE. " IIGM Italian Institute for Genomic Medicine; Human Technopole; PNRR per l'Italia; Club degli Investitori; Politecnico di Milano;MIP Politecnico di Milano

GenomSys is pleased to introduce the new Board that was appointed on July 09th 2024 in Lugano. Dr. Ing. Antonio Aitoro, CEO, Dr. Matteo Colafrancesco, Secretary, and Dr. Luisa Graziani, President & Chairman. On behalf of the whole of shareholders, GenomSys wants to thank Luisa Graziani, who is the CEO of the lead investor ROMED SPA, for her strong and increasing commitment in the Company and for her continuous energetic support. We are proud to have a successful woman at the helm and we’ll continue to boost our presence in the healthcare SW arena leveraging the MPEG-G ISO/IEC 23092 genomic international standard and our integrated platform. Stay tuned. GenomeWeb; GenoGra; IIGM Italian Institute for Genomic Medicine; IEO Istituto Europeo di Oncologia; Human Technopole; EPFL Future Leaders; Diagnostica Longwood; Politecnico di Milano; OGR Torino: LIFTT; Club degli Investitori; Patrizia Carlevaro; Khoso Baluch; Guido Walter Di Donato, PhD; Juri Sacchetta; Massimo Marcarini; Piero Bergamini